Info Request | Media centre | Newsletter | Site Map | in French | Search the site:

Executive Committee (EC)

  • Overview
  • EC Members
  • Meetings & teleconferences

Functions:

The primary function of the Executive Committee shall be

  1. setting the Board agenda and drafting decision points for the Board's consideration;
  2. oversight of the RBM Partnership Secretariat in work plan implementation; and
  3. advice on non-planned activities.

The EC does not execute Board functions. The EC's main role is to generate agenda items for regular or extraordinary Board meetings and draft decision points for the Board to either approve or reject.

The Executive Committee consists of ten members: one Board member from each of the seven constituencies, plus the hosting agency, all with full voting rights. The EC Chair has a casting vote only. The Executive Director is an ex-officio non-voting member of the Executive Committee.  In addition, any Board member may join any EC meeting by teleconference.

Members
Meetings

Related materials

Roll Back Malaria Partnership By Laws
[in English - November 2011 update] [in French]

RBM Partnership Operating Framework
[in English - November 2011 update] [in French]

RBM Conflict of Interest Policy and Procedure
[in English - December 2009]

Memorandum of Understanding between RBM Partnership and WHO, Concerning Hosting, Secretariat and Administrative Services
December 2006
[in English] [in French]

Memorandum of Understanding between The Global Fund and Roll Back Malaria
April 2010
[in English]

External Evaluation of the Roll Back Malaria (RBM) PartnershipExternal Evaluation of the Roll Back Malaria (RBM) Partnership 2009-2013

RBM Change Initiative: Collection of documents

What is the RBM Partnership? [PPT]

External Evaluation of Roll Back Malaria 2004-2008Independent Evaluation of the Roll Back Malaria Partnership 2004-2008
Final Evaluation Report
[in English] [in French]

External Evaluation of Roll Back MalariaExternal Evaluation of Roll Back Malaria 1998-2002
Achieving Impact: Roll Back Malaria in the Next Phase